Pfizer, a major American pharmaceutical company that has developed a new coronavirus vaccine that has begun to be vaccinated in Japan, has announced that it wants to start clinical trials for children under the age of 11.
On the 23rd, a committee of the US Congress held a hearing by inviting executives of five pharmaceutical companies that have signed a contract to supply a vaccine for the new coronavirus with the US government, and gave testimony about the latest development status etc. I asked.
In this, Pfizer executives said, "We will proceed with research on safety and efficacy for use in people who are not subject to the current emergency use authorization," and have already started 12 to 15 years old. In addition to the clinical trials up to now, he revealed that he would like to start clinical trials for children under 11 years old soon.
Pfizer vaccines are currently available to people over the age of 16 in both the United States and Japan.
Moderna also revealed that it is currently considering measures such as conducting clinical trials in stages for people under the age of 18 who are not eligible for vaccination in the United States.
Trade unions made up of American faculty and staff are calling for early start of vaccination of children.
There is growing interest in the benefits and safety of children and the time when vaccinations begin, as it is related to the time when face-to-face classes at schools will resume in earnest in the United States.